Papanicolaou P, Chrysomali E, Stylogianni E, Donta C, Vlachodimitropoulos D. Increased TNF-α, IL-6 and decreased IL-1β immunohistochemical expression by the stromal spindle-shaped cells in the centralgiant cell granuloma of the jaws. Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e56-62.

doi:10.4317/medoral.17205

http://dx.doi.org/doi:10.4317/medoral.17205

1. Potter BJ, Tiner BD. Central giant cell granuloma. Report of a case. Oral Surg Oral Med Oral Pathol. 1993;75:286-9.
http://dx.doi.org/10.1016/0030-4220(93)90137-S

2. Kruse-Lösler B, Diallo R, Gaertner C, Mischke KL, Joos U, Kleinheinz J. Central giant cell granuloma of the jaws: a clinical, radiologic, and histopathologic study of 26 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:346-54.
http://dx.doi.org/10.1016/j.tripleo.2005.02.060
PMid:16504869

3. Horner K. Central giant cell granuloma of the jaws: a clinico-radiological study. Clin Radiol. 1989;40:622-6.
http://dx.doi.org/10.1016/S0009-9260(89)80325-3

4. Motamedi MH, Eshghyar N, Jafari SM, Lassemi E, Navi F, Abbas FM, et al. Peripheral and central giant cell granulomas of the jaws: a demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e39-43.
http://dx.doi.org/10.1016/j.tripleo.2006.12.022
PMid:17428697

5. Lin YJ, Chen HS, Chen HR, Wang WC, Chen YK, Lin LM. Central giant cellgranuloma of the mandible in a 7-year-old boy: a case report. Quintessence Int.2007;38:253-9.
PMid:17334004

6. Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP. Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases. Int J Oral Maxillofac Surg. 1988;17:94-9.
http://dx.doi.org/10.1016/S0901-5027(88)80158-9

7. Chaparro-Avendaño AV, Berini-Aytés L, Gay-Escoda C. Peripheral giant cell granuloma. A report of five cases and review of the literature. Med Oral Patol Oral Cir Bucal. 2005;10:53-7; 48-52.

8. Liu B, Yu SF, Li TJ. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med. 2003;32:367-75.
http://dx.doi.org/10.1034/j.1600-0714.2003.00126.x
PMid:12787044

9. Bonetti F, Pelosi G, Martignoni G, Mombello A, Zamboni G, Pea M, et al. Peripheral giant cell granuloma: evidence for osteoclastic differentiation. Oral Surg Oral Med Oral Pathol. 1990;70:471-5.
http://dx.doi.org/10.1016/0030-4220(90)90213-C

10. Helming L, Gordon S. The molecular basis of macrophage fusion. Immunobiology. 2007;212:785-93.
http://dx.doi.org/10.1016/j.imbio.2007.09.012
PMid:18086379

11. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15:49-60.
http://dx.doi.org/10.1016/j.cytogfr.2003.10.005

12. Itonaga I, Hussein I, Kudo O, Sabokbar A, Watt-Smith S, Ferguson D, et al. Cellular mecha-nisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw. J Oral Pathol Med. 2003;32:224-31.
http://dx.doi.org/10.1034/j.1600-0714.2003.00069.x

13. Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL, et al. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Cyto-kine. 2004;26:138-44.
http://dx.doi.org/10.1016/j.cyto.2004.02.001
PMid:15135808

14. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFalpha potently activates osteo-clasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinolo-gy. 2002;143:1108-18.
http://dx.doi.org/10.1210/en.143.3.1108
PMid:11861538

15. Gamberi G, Benassi MS, Ragazzini P, Pazzaglia L, Ponticelli F, Ferrari C, et al. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. Ann Oncol. 2004;15:498-503.
http://dx.doi.org/10.1093/annonc/mdh091
PMid:14998856

16. Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, et al. Expression of oste-oclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res. 2000;15:640-9.
http://dx.doi.org/10.1359/jbmr.2000.15.4.640
PMid:10780856

17. O’Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG. Osteoclasts constitutively ex-press regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest. 1997;76:457-65.
PMid:9111508

18. Amaral FR, Brito JA, Perdigão PF, Carvalho VM, de Souza PE, Gomez MV, et al. NFATc1 and TNFalpha expression in giant cell lesions of the jaws. J Oral Pathol Med. 2010;39:269-74.
http://dx.doi.org/10.1111/j.1600-0714.2009.00855.x

19. de Souza PE, Gomez RS, Xavier GM, dos Santos JS, Gollob KJ, Dutra WO. Systemic leuko-cyte activation in patients with central giant cell lesions. J Oral Pathol Med. 2005;34:312-7.
http://dx.doi.org/10.1111/j.1600-0714.2004.00276.x
PMid:15817076

20. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8:138-40.
PMid:3303008

21. Tobón-Arroyave SI, Franco-González LM, Isaza-Guzmán DM, Floréz-Moreno GA, Bravo-Vásquez T, Castañeda-Peláez DA, et al. Immunohistochemical expression of RANK, GRalpha and CTR in central giant cell granuloma of the jaws. Oral Oncol. 2005;41:480-8.
http://dx.doi.org/10.1016/j.oraloncology.2004.11.006
PMid:15878752

22. Auclair PL, Cuenin P, Kratochvil FJ, Slater LJ, Ellis GL. A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol. 1988;66:197-208.
http://dx.doi.org/10.1016/0030-4220(88)90094-1

23. Saw S, Thomas N, Gleeson MJ, Bódi I, Connor S, Hortobágyi T. Giant cell tumour and central giant cell reparative granuloma of the skull: do these represent ends of a spectrum? A case report and literature review. Pathol Oncol Res. 2009;15:291-5.
http://dx.doi.org/10.1007/s12253-008-9124-y

24. de Souza PE, Paim JF, Carvalhais JN, Gomez RS. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor. J Oral Pathol Med. 1999;28:54-8.
http://dx.doi.org/10.1111/j.1600-0714.1999.tb01996.x

25. Aragão Mdo S, Piva MR, Nonaka CF, Freitas Rde A, de Souza LB, Pinto LP. Central giant cell granuloma of the jaws and giant cell tumor of long bones: an immunohistochemical comparative study. J Appl Oral Sci. 2007;15:310-6.
http://dx.doi.org/10.1590/S1678-77572007000400013

26. Regezi JA. Comments on the pathogenesis and medical treatment of central giant cell granulo-mas. J Oral Maxillofac Surg. 2004;62:116-8.
http://dx.doi.org/10.1016/j.joms.2003.10.005
PMid:14733232

27. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005;36:945-54.
http://dx.doi.org/10.1016/j.humpath.2005.07.005
PMid:16153456

28. Dai JC, He P, Chen X, Greenfield EM. TNFalpha and PTH utilize distinct mechanisms to in-duce IL-6 and RANKL expression with markedly different kinetics. Bone. 2006;38:509-20.
http://dx.doi.org/10.1016/j.bone.2005.10.007
PMid:16316790

29. Mills BG, Frausto A. Cytokines expressed in multinucleated cells: Paget’s disease and giant cell tumors versus normal bone. Calcif Tissue Int. 1997;61:16-21.
http://dx.doi.org/10.1007/s002239900285

30. Friedrich RE, Eisenmann J, Röser K, Scheuer HA, Löning T. Expression of proteases in giant cell lesions of the jaws, tendon sheath and salivary glands. Anticancer Res. 2010;30:1645-52.
PMid:20592356